John Sharp

This bibliographic record appears to combine outputs from multiple distinct authors sharing the name John Sharp, spanning lymphoma and hematologic oncology research, cancer biology, science education, and career/workplace publications. The lymphoma-focused work centers on real-world clinical outcomes for large B-cell lymphoma, marginal zone lymphoma, Hodgkin lymphoma, and related blood cancers, often using multicenter patient cohort data. Because the topic areas and publication types are highly disparate, it is likely that this name aggregates records from more than one researcher rather than a single coherent research program.

Publication output has been relatively steady at roughly 7-9 papers per year for most of the past decade, with a temporary increase to 16 papers in both 2022 and 2023 before declining again toward 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026